Clinical trial
ROMAZA: Phase I trial of combination therapy with romidepsin and azacitidine in patients with newly diagnosed, relapsed or refractory Acute Myeloid Leukaemia ineligible for conventional chemotherapy
To determine the maximum tolerated dose of Azacitidine in combination with Romidepsin
| Category | Value |
|---|---|
| Study start date | 2013-05-14 |